141 related articles for article (PubMed ID: 399874)
41. [Antirheumatic drug therapy 1986: further uncertainty and new hope].
Krüger K
Fortschr Med; 1987 Jan; 105(1):1-3. PubMed ID: 3493956
[No Abstract] [Full Text] [Related]
42. [Nonsteroidal antirheumatic agents--present status and perspectives].
Curković B
Reumatizam; 2000; 47(2):7-10. PubMed ID: 11552613
[TBL] [Abstract][Full Text] [Related]
43. [Celecoxib].
Babić-Naglić D
Reumatizam; 2001; 48(2):27-8. PubMed ID: 12476745
[No Abstract] [Full Text] [Related]
44. [Non-steroidal antirheumatic agents and misoprostol].
Fritsch WP
Dtsch Med Wochenschr; 1987 Nov; 112(47):1840. PubMed ID: 3119306
[No Abstract] [Full Text] [Related]
45. Proglumetacin (protacine): a promising new treatment of the rheumatic joint.
Rivera IC
Pharmatherapeutica; 1982; 3(3):169-73. PubMed ID: 6982477
[TBL] [Abstract][Full Text] [Related]
46. [The introduction of non-steroidal antirheumatics: is there a rational therapy].
Schlumpf U
Schweiz Med Wochenschr; 1982 Aug; 112(35):1200-8. PubMed ID: 6753142
[TBL] [Abstract][Full Text] [Related]
47. [Anti-inflammatory or antirheumatic agents? Pharmacological activity and therapeutic effectiveness of non-steroid anti-inflammatory drugs: comparative study. III].
Mariani L; Baratelli M
Clin Ter; 1980 Feb; 92(4):331-58. PubMed ID: 7004749
[No Abstract] [Full Text] [Related]
48. Scope of inflammopharmacology.
Rainsford KD
Inflammopharmacology; 2010 Aug; 18(4):155-6. PubMed ID: 20661689
[No Abstract] [Full Text] [Related]
49. Therapy with irritren in rheumatic degenerative diseases.
Georgescu C; Dumitrescu C; Dănău M; Spandonidis S; Costache G
Med Interne; 1986; 24(2):147-51. PubMed ID: 3487823
[TBL] [Abstract][Full Text] [Related]
50. Severe neutropenia due to naproxen therapy in rheumatoid arthritis: a case report and review of literature.
Kalksma R; Jansen TL; Bruyn GA
Neth J Med; 2002 Aug; 60(7):289-91. PubMed ID: 12430576
[TBL] [Abstract][Full Text] [Related]
51. [Adverse effects of non-steroidal anti-inflammatory drugs. II. Adverse effects of heterocyclic enols].
Janiec W; Pietryka B; Pytlik M; Leszczyńska J
Wiad Lek; 1985 Dec; 38(24):1745-50. PubMed ID: 3834676
[No Abstract] [Full Text] [Related]
52. Non-steroid anti-inflammatory agents.
Br Med J; 1970 Aug; 3(5720):449-51. PubMed ID: 5454326
[No Abstract] [Full Text] [Related]
53. [Drug-induced renal disorders in patients with rheumatoid arthritis].
Nakano M; Nishi S; Ueno M; Saito T; Hasegawa H; Arakawa M
Ryumachi; 1996 Oct; 36(5):775-82. PubMed ID: 8969558
[No Abstract] [Full Text] [Related]
54. [On experience with the antirheumatic agent Arcobutina].
Eberl R
Munch Med Wochenschr; 1968 Dec; 110(49):2874-7. PubMed ID: 4885420
[No Abstract] [Full Text] [Related]
55. Hepatotoxicity of antirheumatic drugs.
Tolman KG
J Rheumatol Suppl; 1990 May; 22():6-11. PubMed ID: 2192059
[TBL] [Abstract][Full Text] [Related]
56. [Mechanism of action of non-steroidal antirheumatic agents].
Thumb N
Wien Med Wochenschr; 1982 Dec; 132(23-24):588-92. PubMed ID: 6299014
[TBL] [Abstract][Full Text] [Related]
57. Safety of short-term administration of celecoxib in decompensated cirrhosis.
Campbell MS; Makar GA
Hepatology; 2005 Jul; 42(1):237; author reply 238. PubMed ID: 15892075
[No Abstract] [Full Text] [Related]
58. The impact of selective and non-selective non-steroid anti-inflammatory drugs on secondary hemostasis in healthy volunteers.
Schjerning O; Larsen TB; Damkier P
Thromb Res; 2009 Jun; 124(2):208-12. PubMed ID: 19269020
[TBL] [Abstract][Full Text] [Related]
59. [Antirheumatic drugs in general practice].
Ott VR
Dtsch Med J; 1972 Dec; 23(12):696-701. PubMed ID: 4540583
[No Abstract] [Full Text] [Related]
60. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
Ray WA; MacDonald TM; Solomon DH; Graham DJ; Avorn J
Pharmacoepidemiol Drug Saf; 2003; 12(1):67-70. PubMed ID: 12616850
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
